当前位置:
X-MOL 学术
›
Acta Pharm. Sin. B
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Author correction to ‘VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity’ [Acta Pharmaceutica Sinica B 11 (2021) 420-433]
Acta Pharmaceutica Sinica B ( IF 14.5 ) Pub Date : 2024-02-22 , DOI: 10.1016/j.apsb.2024.02.014 Pengzhao Shang , Rui Gao , Yijia Zhu , Xiaorui Zhang , Yang Wang , Minji Guo , Hui Peng , Min Wang , Juan Zhang
中文翻译:
作者更正“VEGFR2靶向抗体与IFNamut融合调节结直肠癌的肿瘤微环境并表现出有效的抗肿瘤和抗转移活性”[药学报B 11 (2021) 420-433]
更新日期:2024-02-22
Acta Pharmaceutica Sinica B ( IF 14.5 ) Pub Date : 2024-02-22 , DOI: 10.1016/j.apsb.2024.02.014 Pengzhao Shang , Rui Gao , Yijia Zhu , Xiaorui Zhang , Yang Wang , Minji Guo , Hui Peng , Min Wang , Juan Zhang
中文翻译:
作者更正“VEGFR2靶向抗体与IFNamut融合调节结直肠癌的肿瘤微环境并表现出有效的抗肿瘤和抗转移活性”[药学报B 11 (2021) 420-433]